New pill tested for brain conditions linked to down syndrome and Alzheimer's
Disease control
Recruiting now
This is the first study in people to test the safety of an experimental oral drug called Leucettinib-21. It will first be given to healthy volunteers to check for side effects and how the body processes it. Later, a single dose will be given to a small group of men with Down synd…
Phase: PHASE1 • Sponsor: Perha Pharmaceuticals • Aim: Disease control
Last updated Feb 23, 2026 14:56 UTC